Jupiter Topco’s Edwards Lifesciences EW Stock Holding History

Jupiter Topco’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$112M	Buy	+1,240,222	New	+$104M	0.05%	290

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Jupiter Topco's EW Position: Q2 2026 in Review

Jupiter Topco opened a new position in Edwards Lifesciences (EW) in Q2 2026: 1,240,222 shares worth $112M. The stake represents 0.05% of the portfolio and ranks #290 among its holdings.

1,259 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Jupiter Topco held 1,240,222 shares of Edwards Lifesciences worth $112M as of Q2 2026.
Edwards Lifesciences was a new Jupiter Topco position in Q2 2026.
Edwards Lifesciences made up 0.05% of Jupiter Topco's portfolio in Q2 2026, its #290 holding.
1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.